Johnson & Johnson and Guidant Corp. announced a revised acquisition deal this morning that values Guidant at $21.5 billion, about $4 billion lower than the original price, and settles the companies’ lawsuit over J&J’s decision to walk away from the previous deal because of a material adverse effect on Guidant’s financial condition.
No word yet on how much of that $4 billion will make it into the “Spitzer for Governor” campaign war chest. ;^)
Houston's Clear Thinkers
Longtime Houston attorney Tom Kirkendall's observations on developments in law, business, medicine, culture, sports, and other matters of general interest to the Houston business, professional, and academic communities.
